首页> 美国卫生研究院文献>Genome Biology and Evolution >Molecular Evolution of the CYP2D Subfamily in Primates: Purifying Selection on Substrate Recognition Sites without the Frequent or Long-Tract Gene Conversion
【2h】

Molecular Evolution of the CYP2D Subfamily in Primates: Purifying Selection on Substrate Recognition Sites without the Frequent or Long-Tract Gene Conversion

机译:CYP2D亚家族在灵长类动物中的分子进化:纯化基质识别位点上的选择而无需频繁或长途基因转换

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The human cytochrome P450 (CYP) 2D6 gene is a member of the CYP2D gene subfamily, along with the CYP2D7P and CYP2D8P pseudogenes. Although the CYP2D6 enzyme has been studied extensively because of its clinical importance, the evolution of the CYP2D subfamily has not yet been fully understood. Therefore, the goal of this study was to reveal the evolutionary process of the human drug metabolic system. Here, we investigate molecular evolution of the CYP2D subfamily in primates by comparing 14 CYP2D sequences from humans to New World monkey genomes. Window analysis and statistical tests revealed that entire genomic sequences of paralogous genes were extensively homogenized by gene conversion during molecular evolution of CYP2D genes in primates. A neighbor-joining tree based on genomic sequences at the nonsubstrate recognition sites showed that CYP2D6 and CYP2D8 genes were clustered together due to gene conversion. In contrast, a phylogenetic tree using amino acid sequences at substrate recognition sites did not cluster the CYP2D6 and CYP2D8 genes, suggesting that the functional constraint on substrate specificity is one of the causes for purifying selection at the substrate recognition sites. Our results suggest that the CYP2D gene subfamily in primates has evolved to maintain the regioselectivity for a substrate hydroxylation activity between individual enzymes, even though extensive gene conversion has occurred across CYP2D coding sequences.
机译:人类细胞色素P450(CYP)2D6基因与CYP2D7P和CYP2D8P假基因一起是CYP2D基因亚家族的成员。尽管由于其临床重要性而对CYP2D6酶进行了广泛的研究,但尚未完全了解CYP2D亚家族的进化。因此,本研究的目的是揭示人类药物代谢系统的进化过程。在这里,我们通过比较人与新世界猴基因组的14种CYP2D序列,研究了灵长类中CYP2D亚家族的分子进化。窗口分析和统计测试表明,在灵长类动物中CYP2D基因的分子进化过程中,旁系同源基因的整个基因组序列通过基因转换而被广泛均质化。基于在非底物识别位点的基因组序列的邻接树显示CYP2D6和CYP2D8基因由于基因转换而聚集在一起。相反,在底物识别位点使用氨基酸序列的系统树没有将CYP2D6和CYP2D8基因聚类,提示底物特异性的功能限制是在底物识别位点纯化选择的原因之一。我们的研究结果表明,即使在整个CYP2D编码序列之间发生了广泛的基因转换,灵长类动物中的CYP2D基因亚家族也已经进化出可以维持区域选择性,从而维持单个酶之间的底物羟基化活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号